NCT00055809 2013-01-23
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)